Diyabetik Ayağın Yönetimi

Yıl 2018, Cilt: 10 Sayı: 1, 35 - 42, 30.01.2018

Pınar Karakaya , Bahar Özdemir Meral Mert Abdülbaki Kumbasar

Öz

Diyabet hastalığı ilk defa Kapadokyalı Areteus tarafından Diabetes olarak adlandırılmıştır.

Tüm dünyada halen 150 milyon diyabetli olduğu tahmin edilmekte ve her 40

saniyede bir diyabet tanısı konulmaktadır. Diyabet hastalarında kalp ve damar

hastalıkları,beyin kanamaları, felç, yüksek tansiyon, görme kayıpları sık enfeksiyonlar,

diş kayıpları, sindirim sistemi fonksiyon yavaşlamaları, ayaklarda yara ve gangrenler sık

rastlanmaktadır. Karşımıza sık olarak çok su içme, çok idrara çıkma, çok yemek yeme

kaşıntı, sık enfeksiyonlara yakalanma, halsizlik, çabuk yorulma şikayetler ile çıkan hastalarda

açlık kan şekeri değeri 126 mg/dl ve üstünde saptanması veya günün herhangi

bir saatinde bakılan kan şekeri değerinin 200 mg/dl ve üstünde saptanması diyabet tanısını

koydurur. Bu derlemede; diyabet hastalığından, gelişen komplikasyonlarından ve

bunların arasında önemli bir yer tutan diyabetik ayak ve tedavisinden, diyabette eğitimin

öneminden bahsetmeye çalışıldı.

Anahtar Kelimeler

Tip 2 diabet, diyabetik komplikasyonları, diyabetik ayak

Kaynakça

• 1. Atabek E; Kapadokyalı Aretaeus.TDC yayınları,Çelik cilt matb.1973; 4-9. 2. Birmingham Diabetes Survey Working Party:Five-year follow- upreport on the Birmingham Diabetes Survey of , Br Med J 1962;3:301. 3. Yılmaz M.T, İmamoğlu Ş.,Yılmaz C. Diabetes Melitus’un tarihçesi. Diabetes Melitus İstanbul, 2000 ; p: 13-15. 4. Diabetes Care and Research in Europe.The St Vincent Declaration. Diabet Med 1990;7:360. 5. Umesh Masharani,MB,BS,et al.Diabetes Melitus 8.Hypoglycemia. Current Medical Drognosis 8.Treatment40.second. Edition chapter 27 San Francisco 2003; p:1152. 6. BENNET ,P,H:Definition,diagnosis and classification of Diabetes Mellitus and impaired glucose tolerans.Joslin’s Diabetes Mellitus Philadelphia,1994; p:1993. 7. CRYER,P.E.:Glucose,homeostasis,hypoglycemia and,Diabetes Mellitus Williams textbook of Endocrinology;8 Edition,W.B.Saunders Co.Editors:J.D.WILSON,D.W.FOSTER, 1993; p: 989-1080. 8. FAJANS,S.S:Diabetes Mellitus,classification and testing procedures. Endocrinology.Editor:J.DeGROOT.Saunders Co.Philadelphia, 1989; p:1346. 9. ZIMMET,P.DOWSE,G:Type 2 Diabetes Mellitus –Epidemiology and natural history.3rd Internatiomal Symposium on Type 2 Diabetes Mellitus (Proceedings)Editor :MALCOLM, NATTANS,Medicom,Europe,1993;10. 10. Koloğlu S. :Endokronoloji”Temel ve klinik”Medikal Network Ankara ,1996; S:367-418. 11. JENKINS.D.:The Genetıcs of type 1 diabetes mellitus.Diabetes Reviews Internatıonal 1994;3:5-7. 12. WILSON,J.D.,FOSTER,D.W.:Genetics and etiology of Type 1 insulin-dependent diabetes mellitus Williams Textbook of Endocrinology 8 th Edition.WB Saunders Company 1993; p: 1257-1268. 13. Gestational Diabetes Mellitus:ADA:Clinical Practice Recommendations Diabetes Care 2000; 23 (supp 1) p: 77-79. 14. Metzger BE,Coustan DR:Summary& Recommendations of the 4th Internatıonal Workshop-Conference on Gestational Diabetes Mellitus.Diabetes Care 1998; 21 (supp2): 161-167. 15. Jovanovic L:Medical Emergencies in the Patient with Diabetes During Pregrancy.Endocrinol Metab Clin N 2000; Am 29(4) p: 771-787 . 16. ADA Implication of the diabetes control and comlications.Clin diabetes 1993;11: 91-96. 17. Geoffrey H:Foot lesions in patients with diabetes:cause,prevention and treatment.In Coslin’s Diabetes Mellitus.Kahn CR,WeirGC edts,13 th edt,Waverly Comp,USA, 1994;p:962-975. 18. Levin ME:Foot lesion in patients with diabetes mellitus.Choric complications of Diabetes.Michael Brownlee and George L.King edl,Endocrinal Metabs Clin North America 1996; 25 :447-462. 19. Levin ME:The Diabetic Foot.In:Current Therapy in Endocrinology and Metabolism.Bardin WC edt,6 th edt Mosby,1997; p: 486-490. 20. Michael E.Edmonds,A.V.M.Foster. Choric complications of Diabetes Blackwell Scientific Publications editorial Office1994; p: 231. 21. Yılmaz C,Hamulu F,Özgen G,Bayraktar F:Vakalarla Diyabet.Candeğer Yılmaz Editör,Servier Araştırma Grubu Yayınları, 1997;s: 117-134. 22. American Diabetes Association:Standarts of medical care for patients diabetes mellitus(Positions Statement).Diabetes care1998; 21 (suppl 1):23-31. 23. The Diabetes Control and Complications Trial Group:The effects of intensive treatment of diabetes in the development of longterm comlications in IDDM.N Eng J Med1993; 329:977-986. 24. American Diabetes Association.Consensus Development conference on Diabetic Foot Wound Care.Diabetes Care1999; 22:1354-1360. 25. Abboth CA,Vileikyte LR,Williamson SH,Carrington A,Boulton AJM.Multi-centre study of the incidence and predictive risk factors for diabetic foot ulceration. Diabetes Care1998; 21 :1071-1075. 26. Shaw JE,Zimmeth PZBoulton AJM.The epidemiologyof diabetic neuropathy.Diabetes Rev 1999;7 :245-252. 27. Veves A,Murray HJ,et all. The risk of foot ulceration in diabetic patienths with high foot pressures:a prospective study.Diabetologia 1992; 35 :660-3. 28. Vileikyte L.Psychological aspects of diabetic peripheral neuropathy. Diabetes Rev 1999;7:387-394. 42 www.kliniktipdergisi.com 29. Coppini DV,Young Pj, et all.Outcome on diabetic foot complications in relation to clinical examination and quantitative sensory testing.A case-controlled study.Age adjusted vibration perception test is beter than sensivitiy in clinical tests.Diabed Med1998;15 :765-771. 30. Klenerman L,McCabe C,Cogley D,Lang P,White M,Screening for patients at risk of diabetic foot ulceration in a general diabetic outpatient clinic.Diabet Med 1996;13: 562-563. 31. Oyibo S,Jude E,Tarawneh I,Armstrong DG,Harkless LB,Boulton AJM.A comparison of two diabetic foot classification system.Diabet Med 2000;17(Suppll) p:54. 32. Armstrong DG,Lavery LA, Harkless LB.Validation of a diabetic feet.wound classification system:the contribution of depth,infection,and vascular disease to the risk of amputation.Diabetes Care 1998; 21: 855-859. 33. Armstrong DG,Lavery LA, Harkless LB.Treatment-based classification system for assessment and care of diabetic feet.Ostomy Wound Manag 1996;42:50-58. 34. Grayson ML,Gibbons GW, et all.Probing to bone in infected pedal ulcers:a clinical sign of underlying osteomyelitis in diabetic patients.JAMA1997; 273 :721-723. 35. Tentolouris N,Jude EB,SmirnoffI,Knowles EA, Boulton AJM,Methicillinresistant Staphylococcus aureus:an incresing problem in a diabetic foot clinic.Diabet Meed 1999;1:767-771. 36. Caputo GM.The rational use of antimicrobial agents in diabetic foot infections.In: Boulton AJM,Connor H, Cavanagh PR,eds. The Foot in Diabetes 3rd edn.Chichester:John Wiley, 2000;p: 143-152. 37. Young MJ, Boulton AJM,Williams DDR,Mcleod AF,Sonksen PH.A mutticentre study of the prevalance of diabetic neuropaty. Diabetologia1993; 36:150-154. 38. Edmonds ME,Foster AVM.Managing the Diabetic foot.Oxfort: Blackwell Science,2000. 39. Mueller MJ,Diamond JE,Sinacor DR etal.Total contact casting in treatment of diabetic plantar ulcers.Controlled clinical trial.Diabetes Care1989;12 :384-388.Shaw JE,Boulton AJM.The Charcot foot.Foot 1995; 5 :65-70. 40. Garcia R,Suares R.Diabetes Education in Elderly.Patient Educ Couns 1996;29:87-97. 41. Day JL.Diabetes Education.In Textbook of Diabetes.Pickup J and Williams G(Editors) 1991;p:933-939. 42. Kamel N.Diyabetli Hastalarda Eğitim,Diyet,Egrersiz ve Oral Antidiyabetik Tedavi.Tüm yönleriyle Diabetes Mellitus Tedavisi. Erdoğan G(editör)1997;s: 13-48.